Wildtype and A30P Mutant Alpha-Synuclein Form Different Fibril Structures

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Nielsen, Søren Bang ^a   Macchi, Francesca ^a   Raccosta, Samuele ^b,c   Langkilde, Annette Eva ^b   Giehm, Lise ^a,f   Kyrsting, Anders ^d   Svane, Anna Sigrid Pii ^a   Manno, Mauro ^c   Christiansen, Gunna ^e   Nielsen, Niels Christian ^a   Oddershede, Lene ^d   Vestergaard, Bente ^b   Otzen, Daniel Erik ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

^c CNR   (Italy)

^d UNIVERSITY OF COPENHAGEN   (Denmark)

^e AARHUS UNIVERSITY   (Denmark)

^f Zealand Pharma AS   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN; ALPHA SYNUCLEIN A30P; ALPHA SYNUCLEIN FIBRIL; THIOFLAVINE; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; FLUORESCENCE ANALYSIS; LINEAR DICHROISM; NONHUMAN; PROTEIN AGGREGATION; WILD TYPE; X RAY CRYSTALLOGRAPHY; X RAY DIFFRACTION;

ALPHA-SYNUCLEIN; ESCHERICHIA COLI; FLUORESCENT DYES; HUMANS; KINETICS; MICROSCOPY, ELECTRON, TRANSMISSION; MUTATION; PROTEIN MULTIMERIZATION; PROTEIN STRUCTURE, SECONDARY; RECOMBINANT PROTEINS; SCATTERING, SMALL ANGLE; SOLUTIONS; SPECTROMETRY, FLUORESCENCE; THIAZOLES; X-RAY DIFFRACTION;

EID: 84879804769     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067713     Document Type: Article

References (44)

1. Halliday GM, McCann H, Shepherd C, (2012) Evaluation of the Braak hypothesis: how far can it explain the pathogenesis of Parkinson's disease? Expert Rev Neurother 12: 673-686.
2. Spillantini MG, Schmidt ML, Lee VMY, Trojanowski JQ, Jakes R, et al. (1997) α-Synuclein in Lewy bodies. Nature 388: 839-840.
3. Serpell LC, Berriman J, Jakes R, Goedert M, Crowther RA, (2000) Fiber diffraction of synthetic α-synuclein filaments shows amyloid-like cross-β conformation. Proceedings of the National Academy of Sciences 97: 4897-4902.
4. Goldberg MS, Lansbury PT, (2000) Is there a cause-and-effect relationship between alpha-synuclein fibrillization and Parkinson's disease? Nature Cell BIol 2: E115-E119.
5. Krüger R, Kuhn W, Müller T, Woitalla D, Graeber M, et al. (1998) Ala30Pro mutation in the gene encoding α-synuclein in Parkinson's disease. Nat Genet 18: 106-108.
6. Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, et al. (1997) Mutation in the α-synuclein gene identified in families with Parkinson's disease. Science 276: 2045-2047.
7. Conway KA, Lee SJ, Rochet JC, Ding TT, Harper JD, et al. (2000) Accelerated Oligomerization by Parkinson's Disease Linked α-Synuclein Mutants. Annals of the New York Academy of Sciences 920: 42-45.
8. Weinreb PH, Zhen W, Poon AW, Conway KA, Lansbury PT, (1996) NACP, A Protein Implicated in Alzheimer's Disease and Learning, Is Natively Unfolded. Biochemistry 35: 13709-13715.
9. Wood SJ, Wypych J, Steavenson S, Louis JC, Citron M, et al. (1999) Alpha-synuclein fibrillogenesis is nucleation-dependent. Implications for the pathogenesis of Parkinson's disease. J Biol Chem 274: 19509-19512.
10. Giehm L, Otzen DE, (2010) Strategies to increase the reproducibility of α-synuclein fibrillation in plate reader assays. Anal Biochem 400: 270-281.
11. Li J, Uversky VN, Fink AL, (2001) Effect of familial Parkinson's disease point mutations A30P and A53T on the structural properties, aggregation, and fibrillation of human alpha-synuclein. Biochemistry 40: 11604-11613.
12. Bertoncini CW, Fernandez CO, Griesinger C, Jovin TM, Zweckstetter M, (2005) Familial Mutants of α-Synuclein with Increased Neurotoxicity Have a Destabilized Conformation. Journal of Biological Chemistry 280: 30649-30652.
13. Hazy E, Bokor M, Kalmar L, Gelencser A, Kamasa P, et al. (2011) Distinct Hydration Properties of Wild-Type and Familial Point Mutant A53T of α-Synuclein Associated with Parkinson's Disease. Biophysical journal 101: 2260-2266.
14. Cho MK, Kim HY, Fernandez CO, Becker S, Zweckstetter M, (2011) Conserved core of amyloid fibrils of wild type and A30P mutant α-synuclein. Protein Science 20: 387-395.
15. Giasson BI, Uryu K, Trojanowski JQ, Lee VM-Y, (1999) Mutant and wild type human α-synucleins assemble into elongated filaments with distinct morphologies in vitro. Journal of Biological Chemistry 274: 7619-7622.
16. Harada R, Kobayashi N, Kim J, Nakamura C, Han S-W, et al. (2009) The effect of amino acid substitution in the imperfect repeat sequences of α-synuclein on fibrillation. Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease 1792: 998-1003.
17. Lashuel HA, Petre BM, Wall J, Simon M, Nowak RJ, et al. (2002) α-Synuclein, Especially the Parkinson's Disease-associated Mutants, Forms Pore-like Annular and Tubular Protofibrils. Journal of Molecular Biology 322: 1089-1102.
18. Li J, Uversky VN, Fink AL, (2002) Conformational behavior of human alpha-synuclein is modulated by familial Parkinson's disease point mutations A30P and A53T. Neurotoxicology 23: 553-567.
19. Narhi L, Wood SJ, Steavenson S, Jiang Y, Wu GM, et al. (1999) Both Familial Parkinson's Disease Mutations Accelerate α-Synuclein Aggregation. Journal of Biological Chemistry 274: 9843-9846.
20. Conway KA, Harper JD, Lansbury PT, (1998) Accelerated in vitro fibril formation by a mutant α-synuclein linked to early-onset Parkinson disease. Nature medicine 4: 1318-1320.
21. Volles MJ, Lansbury PT, (2003) Zeroing in on the Pathogenic Form of α-Synuclein and Its Mechanism of Neurotoxicity in Parkinson's Disease. Biochemistry 42: 7871-7878.
22. Giehm L, Svergun DI, Otzen DE, Vestergaard B, (2011) Low-resolution structure of a vesicle disrupting α-synuclein oligomer that accumulates during fibrillation. Proceedings of the National Academy of Sciences 108: 3246-3251.
23. Huang C, Ren G, Zhou H, Wang C-c, (2005) A new method for purification of recombinant human [alpha]-synuclein in Escherichia coli. Protein Expression and Purification 42: 173-177.
24. Rodger A (2006) Circular Dichroism and Linear Dichroism. Encyclopedia of Analytical Chemistry: John Wiley & Sons, Ltd.
25. Konarev PV, Petoukhov MV, Volkov VV, Svergun DI, (2006) ATSAS 2.1, a program package for small-angle scattering data analysis. Journal of applied crystallography 39: 277-286.
26. Guinier A, (1939) La diffraction des rayons X aux très petits angles: application à l'étude de phénomènes ultramicroscopiques. Ann Phys Onzieme Serie 12: 161-237.
27. Svergun D, Semenyuk A, Feigin L, (1988) Small-angle-scattering-data treatment by the regularization method. Acta Crystallographica Section A: Foundations of Crystallography 44: 244-250.
28. Sumner Makin O, Sikorski P, Serpell LC, (2007) CLEARER: a new tool for the analysis of X-ray fibre diffraction patterns and diffraction simulation from atomic structural models. Journal of Applied Crystallography 40: 966-972.
29. Huang C, Wikfeldt K, Tokushima T, Nordlund D, Harada Y, et al. (2009) The inhomogeneous structure of water at ambient conditions. Proceedings of the National Academy of Sciences 106: 15214-15218.
30. Clark GNI, Hura GL, Teixeira J, Soper AK, Head-Gordon T, (2010) Small-angle scattering and the structure of ambient liquid water. Proceedings of the National Academy of Sciences 107: 14003-14007.
31. Kuffel A, Zielkiewicz J, (2012) Why the solvation water around proteins is more dense than bulk water. J Phys Chem B 116: 12113-12124.
32. Adachi R, Yamaguchi K, Yagi H, Sakurai K, Naiki H, et al. (2007) Flow-induced Alignment of Amyloid Protofilaments Revealed by Linear Dichroism. J Biol Chem 282: 8978.
33. Dafforn TR, Rajendra J, Halsall DJ, Serpell LC, Rodger A, (2004) Protein Fiber Linear Dichroism for Structure Determination and Kinetics in a Low-Volume, Low-Wavelength Couette Flow Cell. Biophysical Journal 86: 404-410.
34. Marshall KE, Hicks MR, Williams TL, Hoffmann SV, Rodger A, et al. (2010) Characterizing the Assembly of the Sup35 Yeast Prion Fragment, GNNQQNY: Structural Changes Accompany a Fiber-to-Crystal Switch. Biophysical Journal 98: 330-338.
35. Sunde M, Serpell LC, Bartlam M, Fraser PE, Pepys MB, et al. (1997) Common core structure of amyloid fibrils by synchrotron X-ray diffraction. Journal of Molecular Biology 273: 729-739.
36. Dueholm M, Nielsen SB, Hein KL, Nissen P, Chapman MR, et al. (2011) Fibrillation of the Major Curli Subunit CsgA under changing conditions implies robust design of aggregation. Biochemistry 50: 8281-8290.
37. Eanes E, Glenner G, (1968) X-ray diffraction studies on amyloid filaments. J Histochem Cytochem 16: 673-677.
38. Brownstein KR, Tarr CE, (1977) Spin-lattice relaxation in a system governed by diffusion. Journal of Magnetic Resonance (1969) 26: 17-24.
39. Celej MS, Caarls W, Demchenko AP, Jovin TM, (2009) A Triple-Emission Fluorescent Probe Reveals Distinctive Amyloid Fibrillar Polymorphism of Wild-Type α-Synuclein and Its Familial Parkinson's Disease Mutants. Biochemistry 48: 7465-7472.
40. Kamiyoshihara T, Kojima M, Uéda K, Tashiro M, Shimotakahara S, (2007) Observation of multiple intermediates in α-synuclein fibril formation by singular value decomposition analysis. Biochemical and biophysical research communications 355: 398-403.
41. Pedersen JS, Dikov D, Flink JL, Hjuler HA, Christiansen G, et al. (2006) The changing face of glucagon fibrillation: Structural polymorphism and conformational imprinting. J Mol Biol 355: 501-523.
42. Fink AL, (2006) The Aggregation and Fibrillation of α-Synuclein. Accounts of Chemical Research 39: 628-634.
43. van Raaij ME, Segers-Nolten IMJ, Subramaniam V, (2006) Quantitative Morphological Analysis Reveals Ultrastructural Diversity of Amyloid Fibrils from α-Synuclein Mutants. Biophysical journal 91: L96-L98.
44. Segers-Nolten I, van der Werf K, van Raaij M, Subramaniam V (2007) Quantitative characterization of protein nanostructures using atomic force microscopy. IEEE. 6608-6611.